Javascript must be enabled to continue!
BRCA1 Expression Profile in Breast Cancer Patients in West Nusa Tenggara
View through CrossRef
Abstract: Breast cancer is still the highest case in Indonesia. The mortality ratio: incidence of breast cancer in various countries can be influenced by differences in the clinical and biological profiles of tumors like BRCA1 expression status. In addition, several parameters that can be reviewed based on breast cancer incidence such as age and domicile can also be associated with BRCA1 expression. BRCA1 is tumor suppressor gene. This protein works as a cell cycle regulator. Germline mutations of BRCA1 are the main cause of inherited breast cancer. Breast cancer with BRCA1 mutations only contributes 20-40% to breast cancer incidence, but this condition have adverse tumor characteristics with poor prognosis. The aim of this study is to determine the BRCA1 expression profile in breast cancer patients in West Nusa Tenggara based on age and domicile status. A 50 paraffin blocks of breast cancer tissue were examined for BRCA1 expression status using immunohistochemistry techniques. Samples and clinicopathological data were obtained from Pathology Anatomy Laboratory collection in NTB Provincial Hospital and medical records. BRCA1 expression profile in breast cancer patients will be analyzed descriptively using the frequency distribution of BRCA1 expression based on age and domicile. The negative BRCA1 expression is high at age <40 (59.1%) in Central Lombok and East Lombok districts (40%). Negative BRCA1 expression was found at age <40 years, found in two districts in NTB.
Title: BRCA1 Expression Profile in Breast Cancer Patients in West Nusa Tenggara
Description:
Abstract: Breast cancer is still the highest case in Indonesia.
The mortality ratio: incidence of breast cancer in various countries can be influenced by differences in the clinical and biological profiles of tumors like BRCA1 expression status.
In addition, several parameters that can be reviewed based on breast cancer incidence such as age and domicile can also be associated with BRCA1 expression.
BRCA1 is tumor suppressor gene.
This protein works as a cell cycle regulator.
Germline mutations of BRCA1 are the main cause of inherited breast cancer.
Breast cancer with BRCA1 mutations only contributes 20-40% to breast cancer incidence, but this condition have adverse tumor characteristics with poor prognosis.
The aim of this study is to determine the BRCA1 expression profile in breast cancer patients in West Nusa Tenggara based on age and domicile status.
A 50 paraffin blocks of breast cancer tissue were examined for BRCA1 expression status using immunohistochemistry techniques.
Samples and clinicopathological data were obtained from Pathology Anatomy Laboratory collection in NTB Provincial Hospital and medical records.
BRCA1 expression profile in breast cancer patients will be analyzed descriptively using the frequency distribution of BRCA1 expression based on age and domicile.
The negative BRCA1 expression is high at age <40 (59.
1%) in Central Lombok and East Lombok districts (40%).
Negative BRCA1 expression was found at age <40 years, found in two districts in NTB.
Related Results
Abstract 1716: Evaluating the functional impacts of the BRCA1-mTORC2 interaction in breast cancer
Abstract 1716: Evaluating the functional impacts of the BRCA1-mTORC2 interaction in breast cancer
Abstract
Objective: The BRCA1 C-Terminal (BRCT) domain of BRCA1 has been found to interact with three accessory proteins (PRR5, RICTOR, and SIN1) of mTOR complex ...
Abstract 1563: Damage-induced BRCA1 phosphorylation contributes to the timing of end resection
Abstract 1563: Damage-induced BRCA1 phosphorylation contributes to the timing of end resection
Abstract
Germline mutations of BRCA1 predispose women to breast and ovarian cancers. BRCA1 functions as a tumor suppressor. A wealth of evidence has established that...
Breast Carcinoma within Fibroadenoma: A Systematic Review
Breast Carcinoma within Fibroadenoma: A Systematic Review
Abstract
Introduction
Fibroadenoma is the most common benign breast lesion; however, it carries a potential risk of malignant transformation. This systematic review provides an ove...
Desmoid-Type Fibromatosis of The Breast: A Case Series
Desmoid-Type Fibromatosis of The Breast: A Case Series
Abstract
IntroductionDesmoid-type fibromatosis (DTF), also called aggressive fibromatosis, is a rare, benign, locally aggressive condition. Mammary DTF originates from fibroblasts ...
Abstract OI-1: OI-1 Decoding breast cancer predisposition genes
Abstract OI-1: OI-1 Decoding breast cancer predisposition genes
Abstract
Women with one or more first-degree female relatives with a history of breast cancer have a two-fold increased risk of developing breast cancer. This risk i...
Identification of shared neoantigens in BRCA1-related breast cancer
Identification of shared neoantigens in BRCA1-related breast cancer
Personalized neoantigen-based cancer vaccine has been shown to be safe and immunogenic in cancer patients; however, the manufacturing process can be costly and brings about delay i...
Abstract 3596: Characterizing BRCA1 and BRCA2 mutations in Cameroonian breast cancer patients: Efforts towards bridging the genomic gap in Africa
Abstract 3596: Characterizing BRCA1 and BRCA2 mutations in Cameroonian breast cancer patients: Efforts towards bridging the genomic gap in Africa
Abstract
Background:
There are profound global inequities cancer genomics research, with publications focusing on cancer ...
Spanish Breast Cancer Research Group (GEICAM)
Spanish Breast Cancer Research Group (GEICAM)
This section provides current contact details and a summary of recent or ongoing clinical trials being coordinated by Spanish Breast Cancer Research Group (GEICAM). Clinical trials...

